Literature DB >> 30287493

A new era for treatment of drug-resistant tuberculosis.

Neel R Gandhi1, James C M Brust2, N Sarita Shah3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30287493      PMCID： PMC6402770          DOI： 10.1183/13993003.01350-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  24 in total

1.  Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil.

Authors:  Margareth Dalcolmo; Regina Gayoso; Giovanni Sotgiu; Lia D'Ambrosio; Jorge L Rocha; Liamar Borga; Fatima Fandinho; Jose U Braga; Vera M N Galesi; Draurio Barreira; Denise A Sanchez; Fernanda Dockhorn; Rosella Centis; Jose A Caminero; Giovanni B Migliori
Journal:  Eur Respir J       Date:  2017-03-22       Impact factor: 16.671

2.  Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.

Authors:  A Trébucq; V Schwoebel; Z Kashongwe; A Bakayoko; C Kuaban; J Noeske; S Hassane; B Souleymane; A Piubello; F Ciza; V Fikouma; M Gasana; M Ouedraogo; M Gninafon; A Van Deun; D M Cirillo; K G Koura; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2017-11-17       Impact factor: 2.373

3.  Safety and efficacy of exposure to bedaquiline-delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia.

Authors:  Lorenzo Guglielmetti; Linda Barkane; Damien Le Dû; Dhiba Marigot-Outtandy; Jérôme Robert; Nicolas Veziris; Yazdan Yazdanpanah; Liga Kuksa; Eric Caumes; Mathilde Fréchet-Jachym
Journal:  Eur Respir J       Date:  2018-03-22       Impact factor: 16.671

Review 4.  Elucidating the role of clofazimine for the treatment of tuberculosis.

Authors:  M R O'Donnell; N Padayatchi; J Z Metcalfe
Journal:  Int J Tuberc Lung Dis       Date:  2016-12-01       Impact factor: 2.373

5.  Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Authors:  Sergey E Borisov; Keertan Dheda; Martin Enwerem; Rodolfo Romero Leyet; Lia D'Ambrosio; Rosella Centis; Giovanni Sotgiu; Simon Tiberi; Jan-Willem Alffenaar; Andrey Maryandyshev; Evgeny Belilovski; Shashank Ganatra; Alena Skrahina; Onno Akkerman; Alena Aleksa; Rohit Amale; Janina Artsukevich; Judith Bruchfeld; Jose A Caminero; Isabel Carpena Martinez; Luigi Codecasa; Margareth Dalcolmo; Justin Denholm; Paul Douglas; Raquel Duarte; Aliasgar Esmail; Mohammed Fadul; Alexey Filippov; Lina Davies Forsman; Mina Gaga; Julia-Amaranta Garcia-Fuertes; José-María García-García; Gina Gualano; Jerker Jonsson; Heinke Kunst; Jillian S Lau; Barbara Lazaro Mastrapa; Jorge Lazaro Teran Troya; Selene Manga; Katerina Manika; Pablo González Montaner; Jai Mullerpattan; Suzette Oelofse; Martina Ortelli; Domingo Juan Palmero; Fabrizio Palmieri; Antonella Papalia; Apostolos Papavasileiou; Marie-Christine Payen; Emanuele Pontali; Carlos Robalo Cordeiro; Laura Saderi; Tsetan Dorji Sadutshang; Tatsiana Sanukevich; Varvara Solodovnikova; Antonio Spanevello; Sonam Topgyal; Federica Toscanini; Adrian R Tramontana; Zarir Farokh Udwadia; Pietro Viggiani; Veronica White; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2017-05-21       Impact factor: 16.671

6.  Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.

Authors:  L Guglielmetti; C Hewison; Z Avaliani; J Hughes; N Kiria; N Lomtadze; N Ndjeka; S Setkina; A Shabangu; W Sikhondze; A Skrahina; N Veziris; J Furin
Journal:  Int J Tuberc Lung Dis       Date:  2017-02-01       Impact factor: 2.373

7.  Linezolid for treatment of chronic extensively drug-resistant tuberculosis.

Authors:  Myungsun Lee; Jongseok Lee; Matthew W Carroll; Hongjo Choi; Seonyeong Min; Taeksun Song; Laura E Via; Lisa C Goldfeder; Eunhwa Kang; Boyoung Jin; Hyeeun Park; Hyunkyung Kwak; Hyunchul Kim; Han-Seung Jeon; Ina Jeong; Joon Sung Joh; Ray Y Chen; Kenneth N Olivier; Pamela A Shaw; Dean Follmann; Sun Dae Song; Jong-Koo Lee; Dukhyoung Lee; Cheon Tae Kim; Veronique Dartois; Seung-Kyu Park; Sang-Nae Cho; Clifton E Barry
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

8.  Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa.

Authors:  Amrita Daftary; Nesri Padayatchi; Max O'Donnell
Journal:  Glob Public Health       Date:  2014-07-18

9.  Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study.

Authors:  Gabriella Ferlazzo; Erika Mohr; Chinmay Laxmeshwar; Catherine Hewison; Jennifer Hughes; Sylvie Jonckheere; Naira Khachatryan; Virginia De Avezedo; Lusine Egazaryan; Amir Shroufi; Stobdan Kalon; Helen Cox; Jennifer Furin; Petros Isaakidis
Journal:  Lancet Infect Dis       Date:  2018-02-13       Impact factor: 25.071

10.  Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study.

Authors:  Kathryn Schnippel; Norbert Ndjeka; Gary Maartens; Graeme Meintjes; Iqbal Master; Nazir Ismail; Jennifer Hughes; Hannetjie Ferreira; Xavier Padanilam; Rodolfo Romero; Julian Te Riele; Francesca Conradie
Journal:  Lancet Respir Med       Date:  2018-07-11       Impact factor: 30.700
View more
  3 in total

1.  Turbine enzyme's structure in the crosshairs to target tuberculosis.

Authors:  Thomas M Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-19       Impact factor: 11.205

Review 2.  Novel Approaches for the Treatment of Pulmonary Tuberculosis.

Authors:  Zhi Ming Tan; Gui Ping Lai; Manisha Pandey; Teerapol Srichana; Mallikarjuna Rao Pichika; Bapi Gorain; Subrat Kumar Bhattamishra; Hira Choudhury
Journal:  Pharmaceutics       Date:  2020-12-10       Impact factor: 6.321

3.  Total Synthesis of the Antimycobacterial Natural Product Chlorflavonin and Analogs via a Late-Stage Ruthenium(II)-Catalyzed ortho-C(sp2)-H-Hydroxylation.

Authors:  Alexander Berger; Talea Knak; Anna-Lene Kiffe-Delf; Korana Mudrovcic; Vinayak Singh; Mathew Njoroge; Bjoern B Burckhardt; Mohanraj Gopalswamy; Beate Lungerich; Lutz Ackermann; Holger Gohlke; Kelly Chibale; Rainer Kalscheuer; Thomas Kurz
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.